Ca2+ is an important mediator of stimulus-secretion coupling in beta cells of the pancreatic islets, which secrete insulin in response to elevation in plasma glucose concentration. I studied the actions of two lipids, arachidonic acid (AA) and cholesterol, on enzymatically-dissociated single beta cells of rat and mouse, using cytosolic Ca2+ ([Ca2+]i) measurement in conjunction with whole-cell patch-clamp techniques. AA, which is produced in the beta cell upon stimulation with either glucose or acetylcholine, was found to induce a large increase in [Ca2+]i that was dependent on both extracellular Ca2+ entry and intracellular Ca2+ release. Part of the AA-mediated extracellular Ca2+ entry was due to Ca2+ influx through the arachidonate-regulated Ca2+ (ARC) channels, which have not previously been reported in beta cells. The AA-mediated intracellular Ca2+ release was a result of Ca2+ mobilization from multiple inositol trisphosphate (IP3)-sensitive intracellular stores, including the endoplasmic reticulum (ER) and an acidic Ca2+ store that is probably the secretory granules. Therefore, in beta cells, the AA-mediated Ca2+ signal may amplify the [Ca2+]i rise induced by insulin secretagogues. Cholesterol is an integral component of cellular membranes and an important regulator of cellular functions. However, elevation of cholesterol level in the pancreatic islets reduces glucose-stimulated insulin secretion. I found that cholesterol overload impairs the glucose-stimulated [Ca2+]i increase in beta cells by two major mechanisms: the first is a decrease in glucose-stimulated ATP production, which is partly mediated by a decrease in glucose uptake, and the second is the reduction of voltage-gated Ca2+ current density. These effects of cholesterol may partly account for the decreased insulin secretion that develops in patients with type II diabetes, who typically exhibit hypercholesterolemia. In summary, different lipids may mediate beneficial or detrimental effects on Ca2+ regulation in rodent pancreatic beta cells.

We develop a composite multiphysics model of excitation-contraction coupling for a rat ventricular myocyte under voltage clamp (VC) conditions to: (1) probe mechanisms underlying the response to Ca2+-perturbation; (2) investigate the factors influencing its electromechanical response; and (3) examine its rate-dependent behavior (particularly the force-frequency response (FFR)). Motivation for the study was to pinpoint key control variables influencing calcium-induced calcium-release (CICR) and examine its role in the context of a physiological control system regulating cytosolic Ca2+ concentration and hence the cardiac contractile response. Our cell model consists of an electrical-equivalent model for the cell membrane and a fluid-compartment model describing the flux of ionic species between the extracellular and several intracellular compartments. The model incorporates frequency-dependent calmodulin (CaM) mediated spatially heterogenous interaction of calcineurin (CaN) and Ca2+/calmodulin-dependent protein kinase-II (CaMKII) with their principal targets and accounts for rate-dependent, cyclic adenosine monophosphate (cAMP)-mediated up-regulation. We also incorporate a biophysical model for cardiac contractile mechanics to study the factors influencing force response. The model reproduces measured VC data published by several laboratories, and generates graded Ca2+-release with high Ca2+ gain by achieving negative feedback control and Ca2+-homeostasis. We examine the dependence of cellular contractile response on: (1) the amount of activator Ca2+ available; (2) the type of mechanical load applied; (3) temperature (22 to 38ºC); and (4) myofilament Ca2+ sensitivity. We demonstrate contraction-relaxation coupling over a wide range of physiological perturbations. Our model reproduces positive peak FFR observed in rat ventricular myocytes and provides quantitative insight into the underlying rate-dependence of CICR. The role of Ca2+ regulating mechanisms are examined in handling induced Ca2+-perturbations using a rigorous cellular Ca2+ balance. Extensive testing of the composite model elucidates the importance of various direct and indirect modulatory influences on the cellular twitch-response with wide agreement with measured data on all accounts. We identify cAMP-mediated stimulation, and rate-dependent CaMKII-mediated up-regulation of Ca2+-trigger current (ICaL) as the key mechanisms underlying the aforementioned positive FFR. Our model provides biophysically-based explanations of phenomena associated with CICR and provides mechanistic insights into whole-cell responses to a wide variety of testing approaches used in studies of cardiac myofilament contractility.

No description available.

Les arthrogryposes multiples congénitales (AMC), limitations articulaires multiples survenant au cours du développement et présentes à la naissance, sont un ensemble hétérogène de maladies dont le dénominateur commun est une diminution des mouvements fœtaux. Dans la majorité des cas, l'AMC est liée à un mécanisme impliquant le système neuromusculaire. Les causes sont dans un grand nombre de cas d'origine génétique. La connaissance de cette cause permet de proposer un conseil génétique avec une évaluation précise du risque de récurrence et éventuellement un diagnostic anténatal. La connaissance du mécanisme sous-jacent participe à l'évaluation du pronostic et permet d'élargir les connaissances sur la mise en place du système neuromusculaire. Mes travaux de thèse ont porté sur ces deux aspects. Dans un premier temps, j'ai étudié l'expression du récepteur de la ryanodine RyR1 dans le muscle squelettique fœtal humain. Les mutations de RYR1 sont responsables de myopathies congénitales. Dans les formes sévères précoces, une AMC peut être occasionnellement associée. L'expression de RyR1 est détectée dès 14 semaines d'aménorrhée dans le muscle fœtal humain. Ce résultat confirme l'expression précoce de RyR1 chez l'homme et permet d'expliquer la possibilité de limitations articulaires. Dans un second temps, j'ai étudié une famille consanguine avec trois enfants atteints d'arthrogrypose distale à la recherche de la cause génétique sous-jacente. L'analyse pangénomique m'a permis de lier pour la première fois le gène ECEL1, codant une endopeptidase, à une pathologie humaine. La recherche de mutations d'ECEL1 dans une cohorte de 20 patients a permis d'identifier cinq autres familles. Toutes les mutations sont transmises sur un mode autosomique récessif et conduisent à une perte de fonction de la protéine. L'ensemble des patients présentent un phénotype clinique et IRM semblable et distinct des autres tableaux d'arthrogrypose distale. Au total, ces travaux confirment l'expression précoce de RyR1 chez l'homme et identifient le gène ECEL1 comme une cause récurrente d'un type particulier d'arthrogrypose distale autosomique récessive. / Arthrogryposis multiplex congenita (AMC) is a heterogeneous group of disorders characterised by multiple joint contractures at birth due to diminished foetal movements. In most cases, the underlying mechanism involves the neuromuscular system. Genetic causes are frequent. Identifying the genetic cause is paramount for precise recurrent risk assessment, genetic counselling and prenatal diagnosis. Elucidating the underlying mechanism allows for prognostic evaluation and expands our knowledge on the development of the human neuromuscular system. My thesis focused on these two aspects. First I studied the expression of the ryanodine receptor 1 in human foetal skeletal muscle. RYR1 mutations cause congenital myopathies. AMC can occasionally be associated with severe forms of RYR1 related congenital myopathies. RyR1 is expressed at 14 weeks of gestational age in human skeletal muscle. Thus it confirms the early expression of RyR1 in human and can account for the occurrence of joint contractures. Second, in order to identify an underlying genetic cause, I studied a consanguineous family with three affected children showing a distal arthrogryposis phenotype. The genome wide linkage study allowed me to link for the first time the endopeptidase coding gene ECEL1 to a human disease. Five other families were shown to carry ECEL1 mutations after screening a cohort of 20 families with distal arthrogryposis. All mutations were recessive and predicted to lead to a loss of function of the protein. All patients showed a recognisable clinical and MRI phenotype that differed to that of currently known distal arthrogryposes. Altogether, these results confirm the early expression of RyR1 in human and identify ECEL1 as a recurrent cause of a distinct type of distal arthrogryposis.

La contraction des muscles striés est sous la dépendance du Complexe de Relâchement du Calcium (CRC). Ce complexe protéique est constitué principalement de deux canaux calciques, le récepteur des dihydropyridines, un canal sensible au voltage localisé dans la membrane des tubules-T et le récepteur de la ryanodine (RyR) situé dans la membrane du RS. Le CRC comprend également de nombreuses protéines régulatrices comme la triadine, la calséquestrine, la junctine et FKBP. Des mutations dans les gènes codant les protéines du CRC conduisent à des pathologies rares et souvent sévères. Cette thèse porte sur l'étude des mécanismes physiopathologiques induits par quelques unes de ces mutations pour décrypter les mécanismes pathologiques mis en œuvre mais également pour comprendre le fonctionnement global du CRC dans les muscles squelettique et cardiaque. La première partie de cette étude concerne RYR1, le gène codant l'isoforme squelettique du RyR qui est une cible importante de mutations chez des patients atteints de myopathies congénitales à cores. L'effet fonctionnel de ces mutations, réparties sur toute la séquence de RYR1, est peu connu. Ces mutations pourraient modifier la fonction canal de RyR1 mais également son adressage à la triade ou sa régulation par d'autres protéines du CRC. Parmi ces hypothèses, la modification de la localisation de RyR1 et sa régulation par une protéine régulatrice (la cavéoline-3) ont été révélées par l'étude de deux mutations de RyR1. La deuxième partie de cette étude concerne la tachycardie ventriculaire polymorphe catécholaminergique (TVPC), une pathologie liée à des défauts du CRC cardiaque, pour laquelle des recherches de mutations sont effectuées sur l'isoforme cardiaque du RyR, RYR2, puis dans les autres protéines du complexe. Nous avons identifié au laboratoire les premières mutations dans le gène de la triadine chez un de ces patients. L'impact d'une de ces mutations sur le fonctionnement du complexe a été étudié et nous avons pu caractériser le mécanisme physiopathologique mis en œuvre et conduisant à la TVPC chez ces patients. / The calcium release complex (CRC) plays a central role in both skeletal and cardiac muscle contraction. The composition of the complex is quite similar in both tissues, and differs only by tissue specific isoforms. The core of the complex is composed of the dihydropyridines receptor, a voltage sensor channel of the T-tubule and the ryanodine receptor, the sarcoplasmic reticulum calcium channel. A number of proteins are associated to this calcium channel like calsequestrin, triadin, junction and FKBP. Mutations in the skeletal CRC are responsible for rare and often severe diseases. This thesis work focuses on the study of physiopathological mechanisms induced by some of these mutations to decipher pathological mecanisms but also to understand the overall CRC functioning in skeletal and cardiac muscles. The first part of this study concerns RYR1, the skeletal RyR isoform coding gene. This gene is mostly the target of mutations resulting in core myopathies. The functional effect of these mutations spred on the entire RYR1 sequence is little known. These mutations could directly alter the calcium channel function but also its targeting to the triad or its regulation by other CRC proteins. Among these hypotheses, the modification of RyR1 localisation and regulation by a protein, Caveolin-3, have been highlighted with the study of two RyR1 mutations. The second part of this study concerns the catecholaminergic polymorphic ventricular tachycardia (CPVT), a rare fatal arrhythmia caused in part by mutations in RYR2 and CASQ2, both belonging to the cardiac CRC,. Recently, we have identified the first mutations in the human triadin gene, TRDN, in a CPVT patient. The goal of this project was to study the molecular and physiological consequences of one of these TRDN mutations allowing the analysis of the pathological mechanisms of this disease, but also a better understanding of the normal function of the cardiac CRC.

Après la transcription, le pré ARNm subit des étapes de maturation avant de sortir du noyau pour être traduit. Une des étapes de maturation est l'épissage. Il permet de souder les séquences codantes de l'ARNm entre elles (les exons) et d'exclure les régions non codantes (les introns).Des mutations génétiques sont à l'origine de défaut d'épissage. Elles peuvent conduire à des rétentions d'intron, des sauts d'exon et des inclusions de séquences introniques appelées pseudo exons.Ma thèse a porté sur l'utilisation du saut d'exon pour corriger ces inclusions. Je me suis intéressé à deux pathologies : la myopathie à cores et le syndrome de LowePour le premier cas, je me suis intéressé à une mutation dans l'intron 101 du gène RyR1. Cette mutation est à l'origine de la création d'un site donneur d'épissage qui active un site accepteur provoquant l'inclusion d'un pseudo exon de 99 nucléotides. Cette inclusion induit une baisse de la quantité du canal calcique RyR1 dans les cellules du patient. Ce canal permet le couplage entre l'excitation et la contraction musculaire. Ses défauts conduisent à diverses myopathies dont la myopathie à cores. Le patient présentait une hypotonie néonatale, une scoliose et des défauts respiratoires, et n'a jamais acquis la marche. J'ai dessiné des oligonucléotides, je les ai transfectés dans les cellules du patient en culture et ainsi montré par RT PCR que le saut du pseudo exon était possible. Afin d'optimiser l'efficacité pour pouvoir évaluer la restauration au niveau protéique et fonctionnel, j'ai développé un lentivirus exprimant une cassette U7 SmOPT avec les AON choisis. Après transduction des cellules, j'ai pu montrer que le saut du pseudo exon permettait le retour de la protéine et de sa fonctionnalité, cette approche pourrait donc permettre une correction chez le patient.Pour le deuxième cas, j'ai tenté de corriger une mutation du gène OCRL. Cette mutation crée un site donneur d'épissage dans l'intron 4 du gène OCRL et active un site accepteur d'épissage 66 nucléotides en amont. L'inclusion du pseudo exon induit la chute du taux de transcrit OCRL par un mécanisme de "Non sense mediated mRNA Decay". OCRL est une phosphatidyl inositol 5 Phosphatase permettant de réguler la quantité de Ptd Ins(4,5)P2 dans la cellule. Les défauts dans OCRL sont responsables d'une pathologie multisystémique, le syndrome de Lowe. J'ai pu obtenir des fibroblastes cutanés du patient. J'ai transfecté ces cellules avec des AONs choisis pour permettre un saut de l'exon pathogène. J'ai ensuite intégré la séquence des AONs efficaces dans un lentivirus U7. J'ai transduit les cellules du patient en culture et observé un retour de la protéine et un retour de l'activité enzymatique, cette approche pourrait donc théoriquement permettre une correction chez le patient.Ces deux travaux sont les premières preuves de principes de thérapie par modulation de l'épissage pour les myopathies congénitales et pour le syndrome de Lowe. Ils ouvrent la voie à des perspectives de traitement pour ces maladies génétiques. / After transcription, the pre mRNA will undergo different maturation step before getting out of the nucleus for translation. One of these step of maturation is the splicing. It allows to concatenate the coding sequences of the mRNA (the exons) and induces the exclusion of the non coding sequences (the introns).Genetics mutations can lead to splicing defects. These defects could be intron retention, exon skipping and exonisation of intronic sequences called pseudo exons.My thesis work was to evaluate the exon skipping therapy to correct these exonisation. I focuses on two diseases: core myopathy and Lowe syndrome.For the first one, my interest was on a mutation in the 101 th intron of RYR1 gene. This mutation creates a splicing donor site wich unveils a cryptic acceptor site. This leads to the inclusion of a 99 nucleotides pseudo exon. This inclusion induces a decrease of the quantity of the calcium channel RyR1 in the patient cells. This channel allows the excitation-contraction coupling, and therefore the muscular contraction. Defects in this channel lead to different myopathies (eg. core myopathy). The patient present at birth a major neonatal hypotonia, scoliosis and respiratory defects. He has never walked. I designed oligonucleotides (AON), transfected them in the cultured patient cells and showed by RT PCR that exon skipping was possible. In order to optimise the efficiency and to evaluate the rescue at a protein level and at a fonctionnal level, I devellopped a lentivirus which express a U7 Sm OPT cassette with the choosen AONs. After cell transduction, I have shown that exon skipping allowed the rescue of the protein and of its functionnality. This approach could permit a genetic correction for the patientFor the second case, I have tried to correct an OCRL mutation. This upstream creates a splicing donor site and unveils an acceptor site 66 nucleotides before. This leads to the inclusion of a pseudo exon which induces a severe decrease of OCRL transcripts level due to a "non sense mediated mRNA Decay". OCRL is a phosphatidyl inositol 5 Phosphatase, which regulates the Ptd Ins(4,5)P2 pool in the cell. OCRL defects induces a multi systemic disease the Lowe syndrome. I obtained patient cutaneous fibroblasts. I transfected these cells with choosen AONs to correct the splicing defect. I integrated the AONs sequence into a U7 lentiviral cassette. I transduced the cultured patient cells and observed a rescue of the protein with a rescue of its activity. This approach could, theoritically permit a correction in the patient.These two studies are the first proof of concept of splicing modulation therapy for congenital myopathy and for Lowe syndrome. This work offers a lot of perspective for the tratment of these genetic illness

Submitted by Renata Lopes (renatasil82@gmail.com) on 2017-03-07T12:02:26Z No. of bitstreams: 1 danielepiresmagalhaesespiritosanto.pdf: 19885258 bytes, checksum: cc404305a80b23fea7d1a26415bf75bf (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2017-03-07T15:03:55Z (GMT) No. of bitstreams: 1 danielepiresmagalhaesespiritosanto.pdf: 19885258 bytes, checksum: cc404305a80b23fea7d1a26415bf75bf (MD5) / Made available in DSpace on 2017-03-07T15:03:55Z (GMT). No. of bitstreams: 1 danielepiresmagalhaesespiritosanto.pdf: 19885258 bytes, checksum: cc404305a80b23fea7d1a26415bf75bf (MD5) Previous issue date: 2014-08-29 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / A arritmia ventricular maligna é uma das principais causas de morte no mundo. Muitas vezes o início de um episódio de arritmia está associado a uma excitação inoportuna no coração, também denominada extra-sístole, ou Potencial de Ação Espontâneo (PAE). O surgimento de PAEs pode estar relacionado a mudanças estruturais ou moleculares nos canais iônicos e a alterações no ciclo de cálcio intracelular. Anormalidades no ciclo de cálcio podem gerar transientes de cálcio espontâneos (TCEs) e estes podem desencadear Potenciais de Ação Espontâneos (PAEs). Estudos experimentais mostram que o surgimento de TCEs é mais frequente sob a estimulação β-Adrenérgica. Em experimentos recentes, notou-se que a presença de episódios de TCEs em cardiomiócitos saudáveis não desencadeia a geração de PAEs. Em contrapartida, em camundongos com a mutação de super expressão da bomba NCX (NaCa), PAEs foram observados em miócitos isolados e foram relacionados a episódios de TCEs. O principal objetivo deste trabalho foi a simulação da formação de PAEs utilizando modelos computacionais desenvolvidos para cardiomiócitos do ventrículo esquerdo de camundongos. Em particular os modelos computacionais foram capazes de reproduzir os cenários experimentais descritos acima, relacionando a geração de PAEs com a estimulação β-Adrenérgica e alterações de canais iônicos como a mutação NCX. Dessa forma, as simulações computacionais apresentadas neste trabalho permitem uma melhor compreensão dos complexos fenômenos associados a arritmias cardíacas. / Malignant ventricular arrhythmias are the major cause of death around the world. The beginning of an episode of arrhythmia is often associated with ectopic beats in the heart, also called extrasystole, or Spontaneous Action Potential (SAP). The development of SAP may be related to structural or molecular changes in ion channels and changes in intracellular calcium cycle. Abnormalities in calcium cycle can result in Spontaneous Calcium Transientes (SCT) and these can trigger SAP. Experimental studies show that the development of SCT is more common under β1-adrenergic stimulation. However, we found, in recent experiments, that the presence of episodes of SCT in healthy cardiomyocytes does not trigger the development of SAP. On the other hand, on mice presenting mutation of overexpression of NCX (NaCa) pump, SAP were observed in isolated cardiomyocytes and were related to episodes of SCT. Thus, we aimed, in this study, to simulate development of SAP using computational models developed for cardiomyocytes of left ventricle of mice. The computational models were able to reproduce the experimental scenarios described above, relating the development of SAP to the β-adrenergic stimulation and to the changes of ion channels as the NCX mutation. Therefore, the computational simulations showed in this work allow the best comprehension of the complex phenomena associated with cardiac arrhythmia.

Made available in DSpace on 2014-08-20T14:30:08Z (GMT). No. of bitstreams: 1 Dissertacao_giane_silva_linhares.pdf: 488926 bytes, checksum: 2a1b87dca9f0a74faf913e8c6e40713e (MD5) Previous issue date: 2012-12-05 / The incorporation of light-curable resins has been proposed for Mineral Trioxide Aggregate (MTA) to improve its properties and reduce its setting time. The aim of the present study was to assess the pH, calcium-ion release and antibacterial activity of an experimental dual-cure Bis-EMA/MTA-based root-end filling material (E-MTA) in comparison with white-MTA (W-MTA); and to evaluate the influence of the addition of CaCl2 on these properties. Polyethylene tubes filled with the materials were immersed in deionized water for the measurement of pH (digital pH meter) and calcium release (atomic absorption spectrophotometry). The evaluations were performed at 3 and 24 hours and 7, 15 and 30 days. The direct contact test was used for evaluation of antibacterial activity of the materials against E. faecalis 30 min and 24 h after manipulation. All materials presented a variation from an alkaline to nearly neutral pH, and were capable of releasing calcium ions along the 30 days of the study. E-MTA showed a significant lower calcium ion release capacity when compared to W-MTA (P<0.05). The calcium release of E-MTA + 5% CaCl2 was similar to W-MTA (P> 0.05). All materials were 100% effective against E. faecalis at 30 min after manipulation. Reduction in the antibacterial activity was observed for E-MTA with or without the addition of CaCl2 after 24h. The monomer Bis-EMA added to MTA formed a material with lower capacity of calcium release and lower antibacterial activity than W-MTA, in spite of maintaining a similar pH. However, the addition of CaCl2 improved the calcium release of this material / A incorporação de resinas fotopolimerizadas ao agregado de trióxido mineral (MTA) tem sido proposta com o intuito de melhorar as suas propriedades e reduzir o tempo de presa. O objetivo do presente estudo foi avaliar o pH, a liberação de íons cálcio e a atividade antibacteriana de um material retrobturador experimental de polimerização dual a base de Bis-EMA/MTA (MTA-E) em comparação com o MTA-branco (MTA-B); e avaliar a influência da adição de CaCl2 sobre estas propriedades. Tubos de polietileno com os materiais foram imersos em água deionizada. Para medir o pH da água foi utilizado um peagâmetro digital. O cálcio liberado foi determinado pela técnica de espectrometria de absorção atômica. O Teste do Contato Direto foi utilizado para avaliar a atividade antibacteriana dos materiais contra E. faecalis 30 min e 24 h após a manipulação. Todos os materiais apresentaram uma variação de pH de alcalino para quase neutro e foram capazes de liberar íons cálcio durante os 30 dias do estudo. MTA-E mostrou uma capacidade de liberação de íons cálcio significativamente menor que o MTA-B (P<0,05). A liberação de cálcio do MTA-E + CaCl2 5% foi semelhante ao MTA-B (P>0,05). Todos os materiais foram 100% efetivos contra E. faecalis nos 30 minutos após a manipulação. Após 24h uma redução na atividade antibacteriana foi observada para o MTA-E, com ou sem a adição de CaCl2. O monómero Bis-EMA adicionado ao MTA formou um material com baixa capacidade de liberação de cálcio e menor atividade antibacteriana do que MTA-B, apesar de manter um pH semelhante. No entanto, a adição de CaCl2 melhorou a liberação de cálcio deste material

No description available.

No description available.